Patients who need to lower their cholesterol will soon have a powerful new option. On Thursday, the Food and Drug ...

The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.

While tried-and-true high cholesterol treatments like statins are an important way to protect your heart if you have elevated ...

After a frightening few hours in which she was rushed to a hospital and checked for a stroke, she was diagnosed with transient global amnesia (TGA). Luckily, Katie's completely fine now — and you can ...

What a viral self-experiment taught me about metabolism, medicine, and curiosity ...

Lipfendra is a new prescription cholesterol tablet from Merck. Its announced U.S. list price is $10.50 per tablet, which ...

Merck's LIPFENDRA (enlicitide), the first FDA-approved oral PCSK9 inhibitor, approved 16 July 2026 at a list price of $315 for a 30-day supply. Amgen's Repatha (evolocumab) is already available for ...

In most major North American sports, there are winners and there are losers. In soccer, there are draws – or you may refer to them as ties. And as we saw at the 2026 FIFA World Cup final between ...

The greatest therapeutic effects of psychedelics appear to occur long after the drug is gone. New research suggests they ...

If your business needs cash but you don't have the time (or qualifications) to apply for a traditional loan, you might consider taking your case to the people. Crowdfunding lets you bypass some of the ...

If a senior loses weight but also loses significant muscle mass, is the treatment really a success?” GLP-1s are meant for ...